According to IMARC Group’s latest report, titled “Transfection Reagents and Equipment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027.’ the global transfection reagents and equipment market reached a value of US$ 824.2 Million in 2021.Transfection reagents and equipment help researchers modulate gene expression. It is used as an analytical tool for protein synthesis, cell growth and development, and facilitating the study of genetic functions. Besides this, transfection reagents and equipment are also gaining traction in protein therapeutics. Owing to its cost-effectiveness, it finds extensive applications across pharmaceutical and biotechnology companies.

We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report

Request for a PDF sample of this report:  https://www.imarcgroup.com/transfection-reagents-equipment-market/requestsample

The global market is majorly driven by the rapid advancements in transfection technologies. For instance, the advent of CRISPR-CAS9, CAR-T, and three dimensions (3D) transfection technology is creating a positive outlook for the market. Furthermore, a considerable rise in the incidences of cancer across the globe and the escalating demand for improved oncology care have significantly contributed to the market growth. With the rapid outbreak of the COVID-19 pandemic, there has also been a rise in the need for transfection reagents and equipment to develop innovative and effective treatment plans. Other factors, including continual improvements in genomics-based research and an enhanced focus on the development of protein therapeutics, have further provided an impetus to market growth. Looking forward, IMARC Group expects the market to reach US$ 1,322.50 Million by 2027, exhibiting at a CAGR of 7.70% during 2022-2027.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global transfection reagents and equipment market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on product, technology, application and end user.

Competitive Landscape:

  • Bio-Rad Laboratories Inc.
  • Lonza Group AG
  • MaxCyte Inc.
  • Merck KGaA
  • Mirus Bio LLC
  • OriGene Technologies Inc.
  • PerkinElmer Inc.
  • Polyplus-transfection SA
  • Promega Corporation
  • PromoCell GmbH
  • Qiagen N.V.
  • Thermo Fisher Scientific Inc.

Breakup by Product:

  • Reagents
  • Equipment

Breakup by Technology:

  • Biochemical Based Transfection
  • Physical Transfection
  • Viral-Vector Based Transfection 

Breakup by Application:

  • Biomedical Research
  • Protein Production
  • Therapeutic Delivery

Breakup by End User:

  • Pharmaceutical and Biotechnology Companies
  • Academics and Research Institutes 

Breakup by Region:

  • North America (United States, Canada)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Others)
  • Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
  • Latin America (Brazil, Mexico, Others)
  • Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Others)

Ask Analyst for Customization and Explore full report with TOC & List of Figures:  https://bit.ly/3uRceB9

We are updating our reports, If you want latest primary and secondary data (2022-2027) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours.

Key highlights of the report:                                                           

  • Market Performance (2015-2020)
  • Market Outlook (2022-2027)
  • Market Trends
  • Market Drivers and Success Factors
  • The Impact of COVID-19 on the Global Market
  • Value Chain Analysis
  • Structure of the Global Market
  • Comprehensive mapping of the competitive landscape

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us                                                                      

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us

IMARC Group

30 N Gould St Ste R

Sheridan, WY 82801 USA - Wyoming

Email: Sales@imarcgroup.com

Tel No:(D) +91 120 433 0800

Americas: - +1 631 791 1145 | Africa and Europe: - +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800